Finzati - Logo
XOMA logo

XOMA Royalty Corp.

XOMABiotechnology
$0.00
0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$503.77M
Growth
-10.6%
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 60.8%Positive free cash flow · 0.16Reasonable earnings multiple · 15.08Healthy liquidity · 3.37Negative growth trend
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$503.77M
52W Range22.29 - 45.22
Beta0.87
Gross Margin94.30%
Oper. Margin21.83%
Profit Margin60.81%
Debt/Eq1.27
Current Ratio3.37
Quick Ratio3.37
Revenue 5Y-10.63%

Investment DNA

How strong this company looks for long-term investors

57
out of 100
Business Quality
Margins, moat, returns
87/100
Financial Strength
Debt, cash, stability
66/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
54/100
Why this score
Stable or improving margins · 60.8%Positive free cash flow · 0.16Reasonable earnings multiple · 15.08Healthy liquidity · 3.37Negative growth trend

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$39.00
Mean
$44.50
Median
$44.50
High
$50.00

Company Overview

IPO: 6/6/1986
Industry: Biotechnology
P/B i: 4.60
Debt / Equity i: 1.27
Operating Margin: 21.83%
Net Margin: 60.81%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 1.27
Current Ratio: 3.37
Quick Ratio: 3.37
Status: Good

Insider Transactions

Recent executive and insider activity

5 high-volume insider sells detected
BVF PARTNERS L P/IL
Transaction: 07/14/2026
SELL
Change
-772,000
Price
$39.00
Filing
07/16/2026
Type
SELL
Franklin Heather L
Transaction: 07/14/2026
SELL
Change
-9,763
Price
$24.71
Filing
07/14/2026
Type
SELL
Franklin Heather L
Transaction: 07/14/2026
SELL
Change
-6,269
Price
$0.01
Filing
07/14/2026
Type
SELL